CompletedPhase 2NCT00053885
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Studying Pleural mesothelioma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Alliance for Clinical Trials in Oncology
- Principal Investigator
- Thierry Jahan, MDUniversity of California, San Francisco
- Intervention
- PTK787/ZK 222584(drug)
- Enrollment
- 47 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2003 – 2006
Study locations (30)
- Northeast Alabama Regional Medical Center, Anniston, Alabama, United States
- Veterans Affairs Medical Center - Birmingham, Birmingham, Alabama, United States
- Rebecca and John Moores UCSD Cancer Center, La Jolla, California, United States
- Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center, Los Angeles, California, United States
- Naval Medical Center - San Diego, San Diego, California, United States
- Veterans Affairs Medical Center - San Diego, San Diego, California, United States
- UCSF Comprehensive Cancer Center, San Francisco, California, United States
- Veterans Affairs Medical Center - San Francisco, San Francisco, California, United States
- CCOP - Christiana Care Health Services, Newark, Delaware, United States
- Lombardi Cancer Center at Georgetown University Medical Center, Washington D.C., District of Columbia, United States
- Walter Reed Army Medical Center, Washington D.C., District of Columbia, United States
- Veterans Affairs Medical Center - Washington, DC, Washington D.C., District of Columbia, United States
- Broward General Medical Center, Fort Lauderdale, Florida, United States
- Memorial Regional Cancer Center at Memorial Regional Hospital, Hollywood, Florida, United States
- CCOP - Mount Sinai Medical Center, Miami Beach, Florida, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00053885 on ClinicalTrials.govOther trials for Pleural mesothelioma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07192900Fast TILs to Treat Metastatic Cancer Patients With Pleural DiseaseDavid Bartlett, MD
- RECRUITINGNANCT07126509Partial Pleurectomy (Surgery) for Unresectable Pleural MesotheliomaUniversity of Chicago
- RECRUITINGPHASE1, PHASE2NCT07121374NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility StudyUniversity Hospital, Antwerp
- RECRUITINGPHASE1NCT06885697Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including MesotheliomaNational Cancer Institute (NCI)
- RECRUITINGPHASE2NCT06840834Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and ChemotherapyIntergroupe Francophone de Cancerologie Thoracique
- RECRUITINGPHASE2NCT06875076Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural MesotheliomaThe First Hospital of Jilin University
- RECRUITINGPHASE2NCT06790082The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural MesotheliomaAalborg University Hospital
- RECRUITINGPHASE1NCT06566079Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid TumorsInSilico Medicine Hong Kong Limited